The coroner’s office in Greenville, South Carolina, is investigating the death of actress Hayden Panettiere, who died recently at the age of 36. Emergency responders were called to a residence for a woman in "cardiac arrest," and while an autopsy showed "no signs of trauma," a final cause of death is pending further testing. The U.S. Drug Enforcement Administration (DEA) has reportedly joined the investigation into the circumstances of her death.
Panettiere, who began her career in commercials at 11 months old and gained fame on the NBC series *Heroes* at 16, had publicly detailed her long-term struggles with substance abuse and mental health. In a memoir released shortly before her death, she described being given a pill by a team member at age 16 to increase her energy for a red carpet event. She characterized that moment as a "gateway" to a cycle of pharmaceutical use and addiction.
Addiction experts interviewed by the BBC noted that child stars face unique risk factors, including early exposure to adult environments and substances during critical developmental stages. Lucas Trautman, medical director of the Oxford Treatment Center, stated that young actors often have "adult access" to drugs without the maturity or protection to manage it. Additionally, the transition from high-intensity fame to a more private life can create a reliance on substances to replicate the "dopamine of fame," Trautman said.
William Moyers of the Hazelden Betty Ford Foundation observed that Panettiere lived her entire life under public scrutiny, which may have hindered her ability to address mental health issues privately. Panettiere also spoke of the pressure she felt from her mother to excel professionally and described a diagnosis of postpartum depression and the 2023 death of her 28-year-old brother, Jansen, as significant personal challenges.
For the general public and families of young performers, these events draw attention to the specific physical risks of long-term substance use, including heart, liver, and organ damage. Panettiere had previously shared that medical professionals warned her of life-threatening consequences if she did not cease drinking. The inclusion of the DEA in this specific case indicates a potential focus on the supply chain of controlled substances, which can lead to legal scrutiny for associates or medical providers involved in a celebrity’s care.
The incident also signals a continuing trend within the entertainment industry regarding the early death of former child stars. Following the deaths of other young actors like Michelle Trachtenberg and Daveigh Chase within the last year, industry figures and former child actors have called for a reassessment of how the business manages the privacy and mental health of minors. Further information regarding Panettiere’s case is expected following the completion of toxicology reports and the conclusion of the DEA and local coroner investigations.